Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
Researchers are conducting a phase 3, randomized, multicenter, double-masked study to evaluate the effectiveness and safety of intranasal cenegermin compared with a vehicle control in adults with Non-Arteritic Anterior Ischemic Optic Neuropathy NAION. This condition affects the optic nerve and can lead to vision loss. The study aims to determine whether cenegermin can improve visual outcomes for participants. Participants will be randomly assigned to one of two groups one receiving cenegermin spray in each nostril and the other receiving a vehicle spray as a comparator. Treatments are administered intranasally. The study compares these two interventions over a treatment period lasting up to 24 weeks, during which visual acuity and other eye health measures are assessed. Throughout the study, participants will undergo regular assessments including measurements of best corrected visual acuity BCVA using the ETDRS chart, visual field sensitivity tests, and optical coherence tomography OCT to evaluate retinal layers. Safety is monitored by tracking ocular and non-ocular adverse events. The primary outcome is the achievement of a 15-letter or greater improvement in BCVA from baseline to week 24. The total participation duration extends through the 24-week treatment and evaluation period.